Two-year survival rates of anti-TNF-α therapy in psoriatic arthritis (PsA) patients with either polyarticular or oligoarticular PsA.

MLA

Iannone, F., et al. “Two-Year Survival Rates of Anti-TNF-α Therapy in Psoriatic Arthritis (PsA) Patients with Either Polyarticular or Oligoarticular PsA.” Scandinavian Journal of Rheumatology, vol. 44, no. 3, May 2015, pp. 192–99. EBSCOhost, https://doi.org/10.3109/03009742.2014.962081.

APA

Iannone, F., Lopriore, S., Bucci, R., Scioscia, C., Anelli, M. G., Notarnicola, A., & Lapadula, G. (2015). Two-year survival rates of anti-TNF-α therapy in psoriatic arthritis (PsA) patients with either polyarticular or oligoarticular PsA. Scandinavian Journal of Rheumatology, 44(3), 192–199. https://doi.org/10.3109/03009742.2014.962081

Chicago

Iannone, F, S Lopriore, R Bucci, C Scioscia, M G Anelli, A Notarnicola, and G Lapadula. 2015. “Two-Year Survival Rates of Anti-TNF-α Therapy in Psoriatic Arthritis (PsA) Patients with Either Polyarticular or Oligoarticular PsA.” Scandinavian Journal of Rheumatology 44 (3): 192–99. doi:10.3109/03009742.2014.962081.